Abstract
When treated with botulinum toxin A, those patients with peripheral neuropathic pain and allodynia (triggering of pain from stimuli which do not normally provoke pain) at baseline, would appear to have a better outcome.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Botulinum Toxins, Type A / therapeutic use*
-
Double-Blind Method
-
Humans
-
Injections
-
Neuralgia / drug therapy*
-
Neuromuscular Agents / therapeutic use*
-
Treatment Outcome
Substances
-
Neuromuscular Agents
-
Botulinum Toxins, Type A